NCT04010071 2023-03-29Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant TumorsPeking Union Medical College HospitalPhase 2 Unknown60 enrolled
NCT05162898 2022-01-27Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.Henan Cancer HospitalPhase NA Unknown90 enrolled